Administration of recombinant human granulocyte colony-stimulating factor to normal donors: Results of the Spanish National Donor Registry

Bone Marrow Transplantation

Volumn 24, Issue 7, 1999, Pages 723-728

  De La Rubia, J ^a   Martinez C ^b   Solano, C ^b   Brunet, S ^b   Cascon P ^b   Arrieta, R ^b   Alegre, A ^b   Bargay, J ^b   De Arriba, F ^b   Canizo C ^b   Lopez J ^b   Serrano, D ^b   Verdeguer, A ^b   Torrabadella, M ^b   Diaz M A ^b   Insunza, A ^b   De La Serna, J ^b   Espigado, I ^b   Petit, J ^b   Martinez M ^b   Benlloch, L ^b   Sanz, M A ^b   more..

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b NONE

Author keywords

Granulocyte colony stimulating factor; Normal donors; Side effects; Stem cell mobilization

Indexed keywords

CD34 ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; AGED; APHERESIS; ARTICLE; BONE PAIN; CENTRAL VENOUS CATHETERIZATION; CHILD; CLINICAL TRIAL; DRUG MONITORING; DRUG SAFETY; DRUG TOXICITY; FATIGUE; FEMALE; FEVER; HEADACHE; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; MULTICENTER STUDY; NAUSEA; NORMAL HUMAN; ORGAN DONOR; PNEUMOTHORAX; PRIORITY JOURNAL; SPAIN; THROMBOCYTE COUNT;

EID: 0345411489     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701977     Document Type: Article

References (40)

1. Chao NJ, Schriber JR, Grimes K et al. Granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 1993; 81: 2031-2035.
2. Sheridan WP, Begely CG, Juttner CA et al. Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339: 640-644.
3. Bensinger W, Singer J, Appelbaum F et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte colony-stimulating factor. Blood 1993; 81: 1883-1888.
4. Dale DC, Liles WC, Price TH. Renewed interest in granulocyte transfusion therapy. Br J Haematol 1997; 98: 497-501.
5. Jendiroba DB, Lichtiger B, Anaissie E et al. Evaluation and comparison of three mobilization methods for the collection of granulocytes. Transfusion 1998; 38: 722-728.
6. Russell JA, Luider J, Weaver M et al. Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors. Bone Marrow Transplant 1995; 15: 111-115.
7. Bensinger WI, Weaver CH, Appelbaum F et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655-1658.
8. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allograft. Blood 1995; 85: 1659-1665.
9. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666-1672.
10. Urbano-Ispizua A, Solano C, Brunet S et al. Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. Bone Marrow Transplant 1996; 18: 35-40.
11. Russell N, Gratwohl A, Schmitz N. The place of blood stem cells in allogeneic transplantation. Br J Haematol 1996; 93: 747-753.
12. Anderlini P, Körbling M, Dale D et al. Allogeneic blood stem cell transplantation: considerations for donors. Blood 1997; 90: 903-908.
13. Dixon WJ. BMDP Statistical Software. University of California: Berkeley, CA, 1990.
14. Dreger P, Haferlach T, Eckstein V et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994; 87: 609-613.
15. Grigg A, Roberts AW, Houghton S et al. Optimizing dose and schedule of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 1995; 86: 4437-4445.
16. Anderlini P, Przepiorka, Seong D et al. Clinical toxicity and laboratory effects of granulocyte colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charge of the procedures. Transfusion 1996; 36: 590-595.
17. Stroncek DF, Clay ME, Petzoldt ML et al. Treatment of normal individuals with granulocyte colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 1996; 36: 601-610.
18. Majolino I, Cavallaro AM, Bacigalupo A et al. Mobilization and collection of PBSC in healthy donors: a retrospective analysis of the Italian Bone Marrow Transplantation Group (GITMO). Haematologica 1997; 82: 47-52.
19. Tabilio A, Falzetti F, Giannoni C et al. Stem cell mobilization in normal donors. J Hematother 1997; 6: 227-234.
20. Anderlini P, Donato M, Lauppe J et al. Allogeneic blood stem cell collection: 4-year results of the MD Anderson protocol in normal donors. Blood 1998; 92 (Suppl. 1): 120a (Abstr. 485).
21. Parkkali T, Volin L, Sirén MK, Ruutu T. Acute iritis induced by granulocyte colony-stimulating factor used for mobilization in a volunteer unrelated peripheral blood progenitor cell donor. Bone Marrow Transplant 1996; 17: 433-434.
22. Becker PS, Wagle M, Matous S et al. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant 1997; 3: 45-49.
23. Norol F, Bonin P, Charpentier F et al. Apparent reactivation of a red cell alloantibody in a healthy individual after G-CSF administration. Br J Haematol 1998; 103: 256-258.
24. Buckner CD, Clift RA, Sanders JE et al. Marrow harvesting from normal donors. Blood 1984; 64: 630-634.
25. Stroncek DF, Holland PV, Bartch G et al. Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program. Blood 1993; 81: 1940-1946.
26. Fossa SD, Poulsen JP, Anders A. Alkaline phosphatase and lactate dehydrogenase changes during leukocytosis induced by G-CSF in testicular cancer. Lancet 1992; 340: 1544 (letter).
27. Chatta GS, Price TH, Allen RC, Dale DC. Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers. Blood 1994; 84: 2923-2929.
28. Martínez C, Urbano-Ispizua A, Mazzara R et al. Granulocyte colony-stimulating factor administration and peripheral blood progenitor cells collection in normal donors: analysis of leukapheresis-related side effects (letter). Blood 1996; 87: 4916-4917.
29. Stroncek DF, Clay ME, Smith J et al. Changes in blood counts after the administration of granulocyte colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors. Transfusion 1996; 36: 596-600.
30. Arbona C, Prósper F, Benet I et al. Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation. Bone Marrow Transplant 1998; 22: 39-45.
31. Link H, Arseniev L, Bähre O et al. Transplantation of allogeneic CD34+ cells. Blood 1996; 87: 4903-4909.
32. Anderlini P, Nugent ML, Champlin RE, Horowitz MM. Peripheral blood stem cells (PBSC) donation: a 4-year analysis from the International Bone Marrow Transplant Registry (IBMTR) database. Blood 1998; 92 (Suppl. 1): 120a (Abstr. 484).
33. Waller CF, Bertz H, Wenger MK et al. Mobilization of peripheral blood progenitor cells for allogeneic transplantation: efficacy and toxicity of a high-dose rhG-CSF regimen. Bone Marrow Transplant 1996; 18: 279-283.
34. Anderlini P, Przepiorka D, Seong C et al. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim. Transfusion 1997; 37: 507-512.
35. Holm M, Hokland P. Not all healthy donors mobilize hematopoietic progenitor cells sufficiently after G-CSF administration to allow subsequent CD34 purification of the leukapheresis product. J Hematother 1997; 7: 111-113 (letter).
36. Corringham RE, Ho AD. Rapid and sustained allogeneic transplantation using immunoselected CD34(+)-selected peripheral blood from normal donors mobilized by recombinant granulocyte and granulocyte-macrophage colony-stimulating factors (letter). Blood 1995; 86: 2052-2054.
37. Vij R, Brown RA, Adkins D et al. Mobilization of normal donors with G-CSF+ GM-CSF is associated with improved yield of hematopoietic progenitors and increased numbers of activated dendritic cells. Blood 1998; 92 (Suppl. 1): 682a (Abstr. 2810).
38. Sakamaki S, Matsunaga T, Hirayama Y et al. Hematological study of healthy volunteers 5 years after G-CSF (letter). Lancet 1995; 346: 1432-1433.
39. Lane TA. Allogeneic marrow reconstitution using peripheral blood stem cells: the dawn of a new era. Transfusion 1996; 36: 585-589.
40. Goldman J. Peripheral blood stem cells for allografting. Blood 1995; 85: 1413-1415.